Louis Drapeau - Net Worth and Insider Trading
Louis Drapeau Net Worth
The estimated net worth of Louis Drapeau is at least $96,213 dollars as of 2024-12-01. Louis Drapeau is the Vice President and CFO of InSite Vision Inc and owns about 260,000 shares of InSite Vision Inc (INSV) stock worth over $90,350. Louis Drapeau is the Sr. VP Finance, CFO of Nektar Therapeutics and owns about 5,000 shares of Nektar Therapeutics (NKTR) stock worth over $5,700. Louis Drapeau is also the Director of Armata Pharmaceuticals Inc and owns about 71 shares of Armata Pharmaceuticals Inc (ARMP) stock worth over $163. Details can be seen in Louis Drapeau's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Louis Drapeau has not made any transactions after 2015-10-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Louis Drapeau
Louis Drapeau Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Louis Drapeau owns 6 companies in total, including Armata Pharmaceuticals Inc (ARMP) , InSite Vision Inc (INSV) , and Bionovo Inc (BNVIQ) among others .
Click here to see the complete history of Louis Drapeau’s form 4 insider trades.
Insider Ownership Summary of Louis Drapeau
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ARMP | Armata Pharmaceuticals Inc | 2015-10-06 | director |
| INSV | InSite Vision Inc | 2015-11-02 | Vice President and CFO |
| BNVIQ | Bionovo Inc | 2011-05-10 | director |
 | | 2007-03-05 | Sr. VP Finance & CFO |
| | 2007-02-14 | director |
| | 2003-11-03 | CFO & Vice President & Finance |
Louis Drapeau Latest Holdings Summary
Louis Drapeau currently owns a total of 3 stocks. Among these stocks, Louis Drapeau owns 260,000 shares of InSite Vision Inc (INSV) as of July 18, 2011, with a value of $90,350 and a weighting of 93.91%. Louis Drapeau owns 5,000 shares of Nektar Therapeutics (NKTR) as of March 5, 2007, with a value of $5,700 and a weighting of 5.92%. Louis Drapeau also owns 71 shares of Armata Pharmaceuticals Inc (ARMP) as of October 6, 2015, with a value of $163 and a weighting of 0.17%.
Latest Holdings of Louis Drapeau
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| INSV | InSite Vision Inc | 2011-07-18 | 260,000 | 0.35 | 90,350 |
| NKTR | Nektar Therapeutics | 2007-03-05 | 5,000 | 1.14 | 5,700 |
| ARMP | Armata Pharmaceuticals Inc | 2015-10-06 | 71 | 2.30 | 163 |
Holding Weightings of Louis Drapeau
Louis Drapeau Form 4 Trading Tracker
According to the SEC Form 4 filings, Louis Drapeau has made a total of 0 transactions in InSite Vision Inc (INSV) over the past 5 years. The most-recent trade in InSite Vision Inc is the acquisition of 200,000 shares on July 18, 2011, which cost Louis Drapeau around $120,000.
According to the SEC Form 4 filings, Louis Drapeau has made a total of 0 transactions in Nektar Therapeutics (NKTR) over the past 5 years. The most-recent trade in Nektar Therapeutics is the acquisition of 1,000 shares on March 5, 2007, which cost Louis Drapeau around $11,770.
According to the SEC Form 4 filings, Louis Drapeau has made a total of 0 transactions in Armata Pharmaceuticals Inc (ARMP) over the past 5 years. The most-recent trade in Armata Pharmaceuticals Inc is the acquisition of 71 shares on October 6, 2015, which cost Louis Drapeau around $43,900.
Insider Trading History of Louis Drapeau
- 1
Louis Drapeau Trading Performance
GuruFocus tracks the stock performance after each of Louis Drapeau's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Louis Drapeau is -13.71%. GuruFocus also compares Louis Drapeau's trading performance to market benchmark return within the same time period. The performance of stocks bought by Louis Drapeau within 3 months outperforms 1 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Louis Drapeau's insider trading performs compared to the benchmark.
Performance of Louis Drapeau
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2 | | | | | |
| Relative Return to S&P 500(%) | 2.12 | | | | | |
Louis Drapeau Ownership Network
Louis Drapeau Owned Company Details
What does Armata Pharmaceuticals Inc do?
Who are the key executives at Armata Pharmaceuticals Inc?
Louis Drapeau is the director of Armata Pharmaceuticals Inc. Other key executives at Armata Pharmaceuticals Inc include Corporate Controller and PFO Richard Rychlik , director & Chief Executive Officer Deborah Birx , and Chief Financial Officer Julianne Averill .
Armata Pharmaceuticals Inc (ARMP) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Armata Pharmaceuticals Inc (ARMP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Armata Pharmaceuticals Inc (ARMP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Armata Pharmaceuticals Inc (ARMP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Armata Pharmaceuticals Inc Insider Transactions
Louis Drapeau Mailing Address
Above is the net worth, insider trading, and ownership report for Louis Drapeau. You might contact Louis Drapeau via mailing address: C/o Biomarin Pharmaceutical Inc., 371 Bel Marin Keys Blvd., Suite 210, Novato Ca 94949.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
